Lv5
1338 积分 2023-01-09 加入
Generic Protocols for Analytical Validation of Tumor-Informed Circulating Tumor DNA Assays for Molecular Residual Disease: The Blood Profiling Atlas in Cancer's Molecular Residual Disease Analytical Validation Working Group Consensus Recommendation
9天前
已完结
Minimal residual disease as a target for liquid biopsy in patients with solid tumours
12天前
已完结
Advancements in liquid biopsy for breast Cancer: Molecular biomarkers and clinical applications
14天前
已完结
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
14天前
已完结
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial
14天前
已完结
Epigenetic phenotype of plasma cell-free DNA in the prediction of early-onset preeclampsia
23天前
已完结
Sarcomatoid urothelial carcinoma: advances and challenges
1个月前
已完结
Ultrasensitive Detection of Circulating Tumour DNA enriches for Patients with a Greater Risk of Recurrence of Clinically Localised Prostate Cancer
2个月前
已完结
Prognostic implications of uncommon EGFR exon 19 deletion-insertion mutations in non-small cell lung cancer treated with third-generation EGFR-TKIs
2个月前
已完结
Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration-Resistant Prostate Cancer
2个月前
已完结
皖公网安备34019202002308
